Volume 19 (2024)
Volume 18 (2023)
Volume 17 (2022)
Volume 16 (2021)
Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
Uropathology
Do Fibroblast Growth Factor Receptor (FGFR) 2 and 3 Proteins Play a Role in the Prognosis of Invasive Urothelial Bladder Carcinoma?

Shereen Fathy Mahmoud; Nanis Shawky Holah; Alshimaa mahmoud Alhanafy; Marwa Mohammed Serag El-Edien

Volume 19, Issue 1 , January 2024, , Pages 81-88

https://doi.org/10.30699/ijp.2023.2012115.3180

Abstract
  Background & Objective: Bladder carcinoma ranks second in prevalence among males in Egypt. As a family of tyrosine kinases, fibroblast growth factor receptor (FGFR) dysregulation has been linked to some malignancies in humans. The aim of this study is to analyze the clinicopathological data of patients ...  Read More

Uropathology
Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study

Evelyn - Angel

Volume 18, Issue 3 , July 2023, , Pages 257-269

https://doi.org/10.30699/ijp.2023.1972203.3004

Abstract
  The progression and recurrence of urothelial carcinoma (UC) are correlated with carcinoma in situ and urothelial dysplasia. It is frequently challenging to distinguish dysplasia and carcinoma in situ from reactive atypia only based on histological characteristics. In daily practices, 2 of the adjunct ...  Read More

Uropathology
The Prevalence of p16 Expression in Urothelial Bladder Cancer in a Tertiary Care Hospital of Chattogram, Bangladesh

Taniza Farnaz; Pradip Bhattacharjee; M. Shahab Uddin Ahamad; Sharmin Ashraf Rima; Naznin Nahar Momin; Anika Sadaf

Volume 18, Issue 3 , July 2023, , Pages 306-311

https://doi.org/10.30699/ijp.2023.1987551.3070

Abstract
  Background & Objective: p16 is a tumor suppressor gene, loss of which is usually associated with poor epithelial differentiation, resulting in tumor progression, which correlates with aggressive clinical behavior and poor prognosis. CDK 4/6 inhibitors can be used as a therapeutic target in p16 negative ...  Read More

Uropathology
Significance of Vascular Endothelial Growth Factor Expression in the Bladder Urothelial Carcinoma and Its Association with Tumor Grade and Invasiveness

Anika Sadaf; Zillur Rahman; Pradip Bhattacharjee; M. Shahab Uddin Ahamad; Sayeeda Nasreen

Volume 16, Issue 4 , August 2021, , Pages 362-369

https://doi.org/10.30699/ijp.2021.138671.2518

Abstract
  Background & Objective: Vascular Endothelial Growth Factor (VEGF) is one of the newer molecular markers that acts as a central mediator of tumor angiogenesis and is essential for tumor growth, progression, and metastasis. So anti-angiogenic drugs can be used as anticancer therapy. Treatments with ...  Read More

Uropathology
Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas

Mahsa Ahadi; Afshin Moradi; Banafshe Bayat; Hanieh Zham; Seyed Jalil Hosseini; Sara Zahedifar; Afsoon Taghavi

Volume 16, Issue 3 , July 2021, , Pages 297-303

https://doi.org/10.30699/ijp.2021.136330.2493

Abstract
  Background & Objective: Urothelial carcinoma is the seventh most common cancer in the world. The histological classification of papillary carcinoma is one of the most important determinants for its prognosis. Sometimes there is an overlap in the extent of the tumor, and the accurate microscopic diagnosis ...  Read More

Bone & Soft tissue Pathology
Role of FGFR3 in Urothelial Carcinoma

Malik Akanksha; Sundaram Sandhya

Volume 14, Issue 2 , April 2019, , Pages 148-155

https://doi.org/10.30699/ijp.14.2.148

Abstract
  Background and Objective: This study was undertaken to analyze the immunohistochemical expression of fibroblast growth factor receptor (FGFR3) in urothelial carcinoma and correlate its expression with the pathological stage, recurrence and other clinicopathological parameters. Material and Methods: A ...  Read More

Uropathology
Renal Capillary Hemangioma Mimicking Urothelial Carcinoma, A Case Report and Review of the Literature

Bita Geramizadeh; Nadereh Shams; Pouya Iranpour; Mohammad javad Rajabi

Volume 14, Issue 2 , April 2019, , Pages 175-179

https://doi.org/10.30699/ijp.14.2.175

Abstract
  Renal hemangioma is a rare tumor which can be capillary or cavernous. There have been less than 30 renal capillary hemangioma cases reported in the English literature. Herein we will report a case of renal hemangioma which was detected in a 74-year-old man operated with the impression of urothelial ...  Read More